SQLite Web: event_store.db

Update row 129316 in events

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-18T03:05:05.644967+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:437d5eaeeda099ca","evidence_event_ids":["evt_1c1914e351a7"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt","company":"Twist Bioscience Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt","article_chars":2227,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_91dfa6f1e7cf0243","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:26:10.583427+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt","source_event_id":"evt_1c1914e351a7","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"5f063971bb1028d6","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-14","2026-04-09","2026-02-23","2026-02-20","2026-02-12","2026-02-20","2025-08-20","2025-05-08","2025-10-01","2025-08-20"],"entities":[{"asset_class":"equity","name":"Twist Bioscience Corp","relevance":"high","symbol":"TWST","type":"issuer"},{"asset_class":"equity","name":"Adam Laponis","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Fidelity Brokerage Services LLC","relevance":"medium","symbol":"","type":"broker_or_agent"}],"event_type":"listing","information_gaps":["The signal is labeled \u201cdiscovery_sec_filing_delta,\u201d but no prior known state or earlier filing is provided in the prompt, so the \u201cwhat changed vs prior\u201d cannot be determined from the supplied text.","The cleaned text shows multiple transaction lines, but not all fields are fully labeled in a way that allows unambiguous mapping of every column (e.g., whether each dollar figure is total sale value vs. price*shares) beyond the presence of the numbers as written.","No explicit total shares to be sold across all entries is provided in a single consolidated line in the supplied text."],"key_facts":["SEC accession number: 0001959173-26-002971.","Form type: 144.","Filed as of date: 2026-04-17 (DATE AS OF CHANGE: 2026-04-17).","Subject company: Twist Bioscience Corp (CIK: 0001581280; SEC file number: 001-38720).","Reporting owner: Adam Laponis (CIK: 0001827198).","Filing indicates transactions in common stock (NASDAQ listed per text: \u201cNASDAQ Common\u201d).","The filing includes entries referencing \u201cRestricted Stock Vesting\u201d and \u201cESPP Purchase\u201d with associated dates and share counts/dollar amounts (exact line items shown in the text).","Example transaction lines shown in the text include: 7000 shares for 2026-02-12 with $350,000.00; 2085 shares for 2026-02-23 with $97,389.93; 2597 shares for 2026-04-09 with $129,561.48; 3000 shares for 2026-04-14 with $165,000.00; and an earlier line dated 2025-08-20 referencing restricted stock vesting and an ESPP purchase (share counts/dollar amounts present in the text)."],"numeric_claims":[{"label":"Shares (example)","value":"7000"},{"label":"Dollar amount (example)","value":"350000.00"},{"label":"Shares (example)","value":"2085"},{"label":"Dollar amount (example)","value":"97389.93"},{"label":"Shares (example)","value":"2597"},{"label":"Dollar amount (example)","value":"129561.48"},{"label":"Shares (example)","value":"3000"},{"label":"Dollar amount (example)","value":"165000.00"}],"primary_claim":"On 2026-04-17, Twist Bioscience Corp filed SEC Form 144 (accession 0001959173-26-002971) disclosing common stock sale activity by Adam Laponis, including multiple transactions with share quantities and dollar amounts.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Twist Bioscience Corp (TWST) filed a Form 144 on 2026-04-17 disclosing planned sales of common stock by reporting owner Adam Laponis. The filing lists multiple sale/transaction entries tied to restricted stock vesting and an ESPP purchase, with specified share counts and prices.","topics":["SEC Form 144","insider/affiliate sale disclosure","common stock","restricted stock vesting","ESPP purchase"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Twist Bioscience Corp \u00b7 Filed 20260417","ticker":"TWST","tickers":["TWST"],"title":"TWST filed 144","url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel